AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUL 282 min read$ANIX

KUMAR AMIT purchased $17K of ANIX

KUMAR AMIT (Chief Executive Officer) purchased 5,000 shares of Anixa Biosciences Inc (ANIX) at $3.44 on 2026-07-27.

Original reporting
SEC EDGAR · KUMAR AMIT
Published Jul 28, 2026, 2:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 28, 2026, 2:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ANIX
Neutral
low confidence
Mentioned
$ANIX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ANIXNeutralLow
01

Why it matters

The disclosure may slightly improve sentiment, but it does not include new guidance, trial results, contracts, or regulatory updates that would materially reprice the stock.

02

Market read

Traders may note the insider buy as a minor positive signal, but the disclosed dollar amount is small and lacks fundamental catalysts.

03

What to watch

The article provides no context on prior insider activity, total insider ownership changes beyond the post-trade figure, or any concurrent company catalysts.

Relevance 4/10Novelty 4/10Timing: today’s SEC Form 4 filing (filed 2026-07-28)

Background

This is an SEC Form 4 insider transaction by Anixa Biosciences CEO Kumar Amit, reporting an open-market purchase.

Company-level read

Ticker impact

$ANIXNeutralLow confidence
Context

CEO KUMAR AMIT filed a Form 4 open-market purchase of 5,000 shares at $3.44 on 2026-07-27, totaling $17,200.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and should fade without follow-on news.

Evidence & confidence

The filing is primary-source, but it is a small open-market purchase with no 10b5-1 plan and no accompanying operational or financial disclosure.

Market effects

Sector

No clear sector read-through; this is company-specific insider activity.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider open-market buys can be routine liquidity or diversification behavior and may not reflect a material change in outlook.

Key entities

  • issuer
    Anixa Biosciences Inc

    Subject of the Form 4 insider transaction; ticker ANIX.

  • insider
    Kumar Amit

    CEO and officer/director who purchased 5,000 shares at $3.44.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ANIX insider trading history →

Related articles

SEP 11
$ANIXMedAI 8/10

RedChip Companies, Inc.: Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money Show on CNBC and Bloomberg TV

RedChip Companies will air interviews with Anixa Biosciences (NASDAQ:ANIX) and Nexalin Technology (NASDAQ:NXL) on Bloomberg TV and CNBC. Anixa is developing a breast cancer vaccine, while Nexalin focuses on neurostimulation for mental health. Both companies are preparing for key trials and commercialization efforts.

finanznachrichten.de2 min
SEP 17
$INGMHighAI 8/10

PLATINUM EQUITY, LLC (Gores Tom) sold $53.5M of INGM (indirect holdings)

PLATINUM EQUITY, LLC sold 1,968,750 indirectly-held shares of Ingram Micro Holding Corp (INGM) at $27.19 ($53.53M total) on 2026-09-15. Filed jointly with Platinum Equity Investment Holdings, LLC (10% owner), Platinum Equity Investment Holdings IC (Cayman), LLC (10% owner), Platinum Equity InvestCo, L.P. (10% owner), Platinum Equity Investment Holdings V, LLC (10% owner), Platinum Equity Partners V, LLC (10% owner), Platinum Equity Partners V, L.P. (10% owner), Imola JV Holdings, L.P. (10% owner), Ingram Holdco, LLC (10% owner) and Gores Tom (10% owner).

SEC EDGAR1 min
SEP 17
$XBPLow

Avenue RP Opportunities Fund, L.P. (LASRY MARC) purchased $1.5M of XBP (indirect holdings)

Avenue RP Opportunities Fund, L.P. purchased 527,606 indirectly-held shares of XBP Global Holdings, Inc. (XBP) at $2.83 ($1.49M total) across 2 trades on 2026-09-15. Filed jointly with Avenue Global Dislocation Opportunities Fund, L.P. (10% owner), Avenue Europe International Management, L.P. (10% owner), Avenue Capital Management II, L.P. (10% owner), Avenue RP Opportunities Fund GenPar, LLC (10% owner), Avenue Global Dislocation Opportunities GenPar, LLC (10% owner), GL RP Partners, LLC (10% owner), GL Global Dislocation Opportunities Partners, LLC (10% owner) and LASRY MARC (10% owner).

SEC EDGAR1 min